Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20042588rdf:typepubmed:Citationlld:pubmed
pubmed-article:20042588lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1332822lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1332701lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1413190lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1422405lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C1422515lld:lifeskim
pubmed-article:20042588lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:20042588pubmed:issue3lld:pubmed
pubmed-article:20042588pubmed:dateCreated2010-1-21lld:pubmed
pubmed-article:20042588pubmed:abstractTextThere is limited knowledge on the identity of primary CD4(+) T cell subsets selectively targeted by HIV-1 in vivo. In this study, we established a link between HIV permissiveness, phenotype/homing potential, and lineage commitment in primary CD4(+) T cells. CCR4(+)CCR6(+), CCR4(+)CCR6(-), CXCR3(+)CCR6(+), and CXCR3(+)CCR6(-) T cells expressed cytokines and transcription factors specific for Th17, Th2, Th1Th17, and Th1 lineages, respectively. CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells expressed the HIV coreceptors CCR5 and CXCR4 and were permissive to R5 and X4 HIV replication. CCR4(+)CCR6(-) T cells expressed CXCR4 but not CCR5 and were permissive to X4 HIV only. CXCR3(+)CCR6(-) T cells expressed CCR5 and CXCR4 but were relatively resistant to R5 and X4 HIV in vitro. Total CCR6(+) T cells compared with CCR6(-) T cells harbored higher levels of integrated HIV DNA in treatment-naive HIV-infected subjects. The frequency of total CCR6(+) T cells and those of CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells were diminished in chronically infected HIV-positive subjects, despite viral-suppressive therapy. A high-throughput analysis of cytokine profiles identified CXCR3(+)CCR6(+) T cells as a major source of TNF-alpha and CCL20 and demonstrated a decreased TNF-alpha/IL-10 ratio in CXCR3(+)CCR6(-) T cells. Finally, CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells exhibited gut- and lymph node-homing potential. Thus, we identified CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells as highly permissive to HIV replication, with potential to infiltrate and recruit more CCR6(+) T cells into anatomic sites of viral replication. It is necessary that new therapeutic strategies against HIV interfere with viral replication/persistence in discrete CCR6(+) T cell subsets.lld:pubmed
pubmed-article:20042588pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:languageenglld:pubmed
pubmed-article:20042588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20042588pubmed:statusMEDLINElld:pubmed
pubmed-article:20042588pubmed:monthFeblld:pubmed
pubmed-article:20042588pubmed:issn1550-6606lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:ChomontNicola...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:RoutyJean-Pie...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:SekalyRafick-...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:SaidElias AEAlld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:Diaz-Griffero...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:AncutaPetrone...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:BoulasselMoha...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:MonteiroPatri...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:El-FarMohamed...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:FonsecaSimone...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:GosselinAnnie...lld:pubmed
pubmed-article:20042588pubmed:authorpubmed-author:WaclecheVanes...lld:pubmed
pubmed-article:20042588pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20042588pubmed:day1lld:pubmed
pubmed-article:20042588pubmed:volume184lld:pubmed
pubmed-article:20042588pubmed:ownerNLMlld:pubmed
pubmed-article:20042588pubmed:authorsCompleteYlld:pubmed
pubmed-article:20042588pubmed:pagination1604-16lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:meshHeadingpubmed-meshheading:20042588...lld:pubmed
pubmed-article:20042588pubmed:year2010lld:pubmed
pubmed-article:20042588pubmed:articleTitlePeripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.lld:pubmed
pubmed-article:20042588pubmed:affiliationDepartment of Microbiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:20042588pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20042588pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20042588pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20042588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20042588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20042588lld:pubmed